Literature DB >> 9797392

Somatostatin and hepatocellular carcinoma.

C R Kapadia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9797392     DOI： 10.1016/s0016-5085(98)70109-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

Review 1.  Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?

Authors:  Kiki Pistevou-Gompaki; Nikos Eleftheriadis; Damianos Eleftheriadis; Christos Papaloukas; Apostolos Hatzitolios
Journal:  Clin Med Oncol       Date:  2008-05-13

3.  Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?

Authors:  Kiki Pistevou-Gompaki; Nikos Eleftheriadis; Christos Papaloukas; Damianos Eleftheriadis
Journal:  Clin Med Oncol       Date:  2008-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.